
CLX is using cost savings, ERP optimization and pricing to cushion inflation, but the FY27 gross margin is still projected at 42%.
The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.
| Revenue (TTM) | $6.72B |
| Gross Profit (TTM) | $2.84B |
| EBITDA | $1.14B |
| Operating Margin | 12.90% |
| Return on Equity | 163.80% |
| Return on Assets | 8.32% |
| Revenue/Share (TTM) | $55.18 |
| Book Value | $0.74 |
| Price-to-Book | 126.70 |
| Price-to-Sales (TTM) | 1.68 |
| EV/Revenue | 2.497 |
| EV/EBITDA | 14.37 |
| Quarterly Earnings Growth (YoY) | -50.10% |
| Quarterly Revenue Growth (YoY) | -2.00% |
| Shares Outstanding | $120.93M |
| Float | $120.53M |
| % Insiders | 0.72% |
| % Institutions | 88.44% |
Volatility is currently contracting

CLX is using cost savings, ERP optimization and pricing to cushion inflation, but the FY27 gross margin is still projected at 42%.

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Clorox (CLX). But which of these two stocks offers value investors a better bang for their buck right now?

Buy these undervalued dividend stocks that have healthy yields to generate dependable income.

Clorox (CLX +0.45%) could be an interesting stock to consider for dividend investors.

CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.

CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.

CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.

I reiterate a Hold rating on The Clorox Company, as the current valuation requires unsustainably high free cash flow growth. Recent positives include the GOJO acquisition and ERP rollout, but organic revenue growth remains limited after adjusting for these factors. CLX's balance sheet is heavily leveraged post-acquisition, constraining reinvestment and raising dividend sustainability concerns.

OAKLAND, Calif., Aug. 19, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle and Chief Financial Officer Luc Bellet will participate in a fireside chat at the Barclays Global Consumer Staples Conference on Wednesday, September 9, in Boston.

Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of Newell Brands (NWL) and Clorox (CLX). But which of these two companies is the best option for those looking for undervalued stocks?
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CLX and any ticker you trade — then tracks every position and per-strategy win rate.